189 related articles for article (PubMed ID: 533262)
1. Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates.
Jones RN; Barry AL; Fuchs PC; Gavan TL; Sommers HM; Gerlach EH
Antimicrob Agents Chemother; 1979 Dec; 16(6):823-8. PubMed ID: 533262
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics.
Finland M; Garner C; Wilcox C; Sabath LD
J Infect Dis; 1976 Nov; 134 SUPPL():S297-307. PubMed ID: 825588
[TBL] [Abstract][Full Text] [Related]
3. Gentamicin and amikacin---an in vitro comparison using 1000 clinical isolates.
Forgan-Smith WR; McSweeney RJ
Aust N Z J Med; 1978 Aug; 8(4):383-6. PubMed ID: 282852
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
DiPersio JR; Krafczyk TL
Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
Yourassowsky E; Schoutens E; Vanderlinden MP
Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
[TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
Schassan HH
Infection; 1976; 4(2):35-41. PubMed ID: 789246
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
Knothe H
J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
[TBL] [Abstract][Full Text] [Related]
9. Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.
Moellering RC; Wennersten C; Kunz LJ; Poitras JW
Am J Med; 1977 Jun; 62(6):873-81. PubMed ID: 868901
[TBL] [Abstract][Full Text] [Related]
10. 3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility tests.
Barry AL; Jones RN; Thornsberry C; Gavan TL; Gerlach EH; Sommer HM
Eur J Clin Microbiol; 1984 Dec; 3(6):531-7. PubMed ID: 6441709
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of netilmicin, gentamicin, and amikacin.
Kantor RJ; Norden CW
Antimicrob Agents Chemother; 1977 Jan; 11(1):126-31. PubMed ID: 402104
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics.
Kelly MT; Matsen JM
Antimicrob Agents Chemother; 1976 Mar; 9(3):440-7. PubMed ID: 1259402
[TBL] [Abstract][Full Text] [Related]
13. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms.
Rahal JJ; Simberkoff MS; Kagan K; Moldover NH
Antimicrob Agents Chemother; 1976 Apr; 9(4):595-9. PubMed ID: 817661
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus.
Díez Enciso M; Mateos Lindemann M; Gutiérrez Altés A
Antimicrob Agents Chemother; 1982 Dec; 22(6):1064-6. PubMed ID: 6818899
[TBL] [Abstract][Full Text] [Related]
16. In vitro studies with Win 42122-2: comparison with gentamicin, netilmicin, and amikacin.
Sanders CC; Sanders WE
Antimicrob Agents Chemother; 1981 Aug; 20(2):247-51. PubMed ID: 7283421
[TBL] [Abstract][Full Text] [Related]
17. In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin.
Dhawan V; Marso E; Martin WJ; Young LS
Antimicrob Agents Chemother; 1977 Jan; 11(1):64-73. PubMed ID: 836015
[TBL] [Abstract][Full Text] [Related]
18. Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates.
Price KE; DeFuria MD; Pursiano TA
J Infect Dis; 1976 Nov; 134 SUPPL():S249-61. PubMed ID: 62814
[TBL] [Abstract][Full Text] [Related]
19. Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns.
Acar JF; Witchitz JL; Goldstein F; Talbot JN; Le Goffic F
J Infect Dis; 1976 Nov; 134 SUPPL():S280-5. PubMed ID: 825587
[TBL] [Abstract][Full Text] [Related]
20. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
Reynolds AV; Hamilton-Miller JM; Brumfitt W
Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
